NCLA: Proposed 'Drug Pricing Rule' Gives Centers for Medicare and Medicaid Services Unwarranted Authority

Tuesday, December 18, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NCLA Submits Comment to HHS and CMS Critical of Rulemaking

WASHINGTON, Dec. 17, 2018 /PRNewswire/ -- The New Civil Liberties Alliance today submitted a Comment in response

to a Proposed Rule from the Department of Health and Human Services (HHS), Centers for Medicare and Medicaid Services (CMS). The so-called Drug Pricing Rule would require direct-to-consumer television advertisements for certain prescription drugs to contain statements indicating the "wholesale acquisition cost" for a typical course of treatment. NCLA believes the Rule is flawed in that CMS lacks the statutory authority to regulate the subject of pharmaceutical market efficiency. Further, even if CMS had the authority to regulate this subject matter, it still lacks the authority to implement the restriction on television advertisement as the proposed regulatory means. NCLA recommends that CMS withdraw the proposed Rule from the Federal Register and notify interested parties that CMS will not pursue compelled disclosure of wholesale acquisition costs in advertisements of any kind.

The New Civil Liberties Alliance released the following statements:

"While there is no doubt that lower drug prices would aid CMS in its administration of Medicare and Medicaid, Congress has not authorized CMS to compel private parties to make public disclosures of drug pricing or to regulate drug advertising on television. Without such authority, CMS lacks the legal basis to promulgate the Drug Pricing Rule."—Michael P. DeGrandis, Senior Litigation Counsel of NCLA

"CMS's rulemaking authority is broad, but 'broad' does not mean 'unlimited.' HHS and CMS should curb their unlawful exercise of administrative power and withdraw the Proposed Drug Pricing Rule before the federal courts have to get involved." —Mark Chenoweth, Executive Director and General Counsel of NCLA

About NCLANCLA is a nonprofit civil rights organization founded by prominent legal scholar Philip Hamburger to protect constitutional freedoms from violations by the administrative state. NCLA's pro bono public-interest litigation and other advocacy strive to tame the unchecked power of state and federal agencies and to foster a new civil liberties movement that will help restore Americans' fundamental rights. For more information visit us online: NCLAlegal.org

Media Inquiries: For interviews with our subject matter experts please contact Judy Pino, 202-869-5218 or email Judy.Pino@NCLA.legal  

Cision View original content:http://www.prnewswire.com/news-releases/ncla-proposed-drug-pricing-rule-gives-centers-for-medicare-and-medicaid-services-unwarranted-authority-300767823.html

SOURCE New Civil Liberties Alliance



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store